Biotechnology News

October 7, 2014

PLEASANTON, Calif.--(BUSINESS WIRE)--Majority of CROs Exchange Regulated Clinical Trial Documents via Outdated, Hard-to-track Methods - New survey signals opportunity for CROs to create competitive advantage in rapidly growing market

October 7, 2014

PITTSBURGH--(BUSINESS WIRE)--CardiacAssist announced that the first PROTEK Duo case in the world was performed at Memorial Hermann Hospital in Houston, Texas on September 24, 2014.

October 7, 2014

ROCKLAND, Mass.--(BUSINESS WIRE)--EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, The Institute of Cancer Research (ICR), and the Wellcome Trust, London, today announced a co-development

October 7, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research is presenting at the 10th Annual Meeting of the Oligonucleotide Therapeutics Society being held on October 12-15, 2014 in San Diego.

October 7, 2014

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene to present Otezla data at European Academy of Dermatology and Venereology Congress

October 7, 2014

ABINGDON, England--(BUSINESS WIRE)--Atopix Therapeutics Ltd (“Atopix”), a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, today announced the addition of SR One to its investor syndicate and the appointment...

October 7, 2014

FAIRFAX, Va.--(BUSINESS WIRE)--ICF has been awarded a single-award BPA from NIH re-compete contract.

October 7, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus’ Intralesional PV-10 to Be Presented at the 2014 Beijing International Melanoma Congress

October 7, 2014

LONDON--(BUSINESS WIRE)--RSA, the leading global Life Sciences Executive Search and Interim Management specialist, today announced the addition of three talented consultants to its already strong teams located across Europe.

October 7, 2014

DARMSTADT, Germany--(BUSINESS WIRE)--Merck Serono, the biopharmaceutical division of Merck, The Institute of Cancer Research (ICR), and the Wellcome Trust, London, today announced a co-development and license agreement

October 7, 2014

BOSTON--(BUSINESS WIRE)--Allied Minds launches Novare Pharmaceuticals, a biotechnology firm focused on developing therapeutic products that help the body rebuild itself using its own tissue through RHAMM modulation.

October 6, 2014

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma (OTCQB: TRGM) supports the AAN guidelines for opioid use in chronic pain, and releases more information about the medical food Theramine as a possible replacement therapy.

October 6, 2014

RICHMOND, Va.--(BUSINESS WIRE)--On Thursday, October 9th, science teachers from public and private schools as well as community colleges across the Commonwealth of Virginia will descend on local life science companies to learn first-hand how...

October 6, 2014

ANAHEIM, Calif.--(BUSINESS WIRE)--More than 1,000 health and human services professionals from across the country are attending CONNECTIONS2014 -- the largest such IT-focused event.

October 6, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced initiation of patient enrollment in the pivotal portion of its IGNITE 2 Phase 3 clinical trial, a two-part trial studying the efficacy and safety of...

October 6, 2014

BOSTON & SEATTLE--(BUSINESS WIRE)--NanoString Technologies has signed a collaboration with Harvard-affiliated Brigham and Women’s Hospital to accelerate the translation of genomic biomarker discoveries into clinical cancer diagnostics.

October 6, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced that data from its infectious disease portfolio will be presented at ID Week 2014, October 8-12 in Philadelphia, Pennsylvania. “The Medicines Company continues...

October 6, 2014

BOSTON--(BUSINESS WIRE)--(Click to Tweet This News) - Flex Pharma, Inc., a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders, today announced the appointment of Marina Hahn as President of...

October 6, 2014

VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the 2014 Fourth Quarter and Fiscal Year End on Thursday, October 30, 2014 prior to the opening of trading on...

October 6, 2014

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) released the following statement today in response to a misleading segment on the cost of innovative cancer therapies on this week’s 60 Minutes. The following statement...

October 6, 2014

WASHINGTON--(BUSINESS WIRE)--PointClickCare announced the availability of its Change in Condition Evaluation Solution, which helps providers better monitor resident health status, reducing hospital readmissions.

October 6, 2014

SASKATOON, Saskatchewan--(BUSINESS WIRE)--Golden Rice, GMO mosquitoes and 3-D Food printing:
The Agricultural Biotechnology International Conference (ABIC 2014) is in Saskatoon, SK, Oct 5-8 featuring 44 internationally renowned speakers

October 6, 2014

MILFORD, Conn.--(BUSINESS WIRE)--DNA Sequencing is necessary to validate standard HPV test results for optimum cervical cancer screening and patient care.

October 6, 2014

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2014 fourth quarter results, Friday, October 10, 2014, at 8:30 AM E.T. To listen to the conference call dial 1-888-459-5609. International...

October 6, 2014

DENVER--(BUSINESS WIRE)--Colorado team will tout the State’s growing medical device and diagnostic sectors during the 2014 AdvaMed: The MedTech Conference in Chicago, IL, October 6-8.

October 6, 2014

SUNNYVALE, Calif.--(BUSINESS WIRE)--Phase 3 study completed for IBI-10090, the first drug candidate utilizing Icon's Verisome® drug-delivery technology

October 6, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX) announced today that Michael H. Mulroy and Stephen L. Cartt are joining its Board of Directors. Mr. Mulroy has been appointed to the Board to fill a vacancy and Mr. Cartt has been...

October 6, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced the results of its strategic review of core therapeutic areas for the Company. The review included an extensive evaluation of Teva’s current and future...

October 6, 2014

RALEIGH, N.C.--(BUSINESS WIRE)--BioPontis Alliance for Rare Disease Offers Enabling Bridge Between Basic Research and Treatments

A NICHE PHILANTHROPY

October 6, 2014

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Sevion Therapeutics (OTCQB:SVON), a clinical stage company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, announced today that Ronald A...

October 6, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced the Company will be exhibiting at the 2014 Congress of Neurological Surgeons (CNS) Annual Meeting, to be held in Boston, MA October 18-22. The exhibit,...

October 6, 2014

BOSTON--(BUSINESS WIRE)--MetaStat (MTST) will be presenting at the BIO Investor Forum in San Francisco on October 8 at 2:00 PM PDT, with an accompanying webcast.

October 6, 2014

ST. LOUIS--(BUSINESS WIRE)--Appistry, Inc., a leading provider of tools, software, and services that bring the power of genomics to next-generation medicine, has selected the winner of its inaugural Appistry Pipeline Challenge. A project team led...

October 6, 2014

EL PASO, Texas--(BUSINESS WIRE)--Premier Biomedical Announces the Addition of Dr. Patricio Reyes to Scientific Advisory Board

October 6, 2014

SAN DIEGO--(BUSINESS WIRE)--bioTheranostics, Inc., a leader in molecular diagnostics for cancer, appointed life sciences industry veteran Nicolas Barthelemy to positions of president and CEO. Barthelemy succeeds Richard Ding.

October 6, 2014

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Announces Collaboration to Evaluate Opdivo (nivolumab) in Combination with Targeted Therapies from Novartis to Treat Non-Small Cell Lung Cancer (NSCLC)

October 6, 2014

HOUSTON & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb and MD Anderson Cancer Center Announce Novel Research Collaboration in Immuno-Oncology Focused on Leukemia and Hematologic Malignancies

October 6, 2014

ALAMEDA, Calif. & JERUSALEM--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), HBL Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY) and Cell Cure Neurosciences Ltd. (Cell Cure) today announced that Cell Cure has filed an Investigational New...

October 6, 2014

NESS ZIONA, Israel--(BUSINESS WIRE)--Kadimastem announces that it approached the FDA regarding the cellular treatment it is developing for ALS. This is the initial approach the company is making to the FDA.

October 6, 2014

CAMBRIDGE, Mass. & HOUSTON--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) and Bellicum Pharmaceuticals, Inc. today announced a restructuring of their license agreement for ARIAD’s cell-signaling technology. ARIAD will receive $50...

October 6, 2014

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Community Health Centers of Arkansas, a state-wide network of community health centers, has selected the eClinicalWorks Care Coordination Medical Record solution for its 122 members in 58 locations.

October 6, 2014

TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Completes Single Ascending Dose Portion of ATB-346 Phase I Program

October 6, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen announced that aspects of its predictive approach to therapeutics discovery as applied to novel immune checkpoints will be presented in poster sessions at 3 leading scientific conferences.

October 6, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX) today announced that it has agreed to sell up to an aggregate of 9,431,398 common shares, in a registered direct offering at an offering price of $3.12 per share. The price per share...

October 6, 2014

BUFFALO GROVE, Ill.--(BUSINESS WIRE)--RestorGenex Corporation (OTCQB: RESX), a specialty biopharmaceutical company initially focused on developing products for dermatology, ophthalmology and women’s health, today announced that Chief Scientific...

October 6, 2014

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX announces that Dr. Subhasish “Babu” Purkayastha, Director, R&D at AB SCIEX, has been awarded the HUPO Science and Technology Award for development of ITRAQ chemistries.